Ideaya Biosciences Profit Margin

The latest profit margin for IDYA is -74.75% as of June 2026. That compares with -4728.99% in the prior-year period — up 98.4% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Ideaya Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, IDYA's profit margin moved from -4728.99% to -74.75% — a 98.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ideaya Biosciences's valuation or profitability profile.

Against Healthcare companies, IDYA currently prints -74.75% for profit margin, while the sector average sits near 21.34%. That is roughly 450.4% below the sector mean. Large gaps often invite a closer look at Ideaya Biosciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Ideaya Biosciences converts resources into returns. At -74.75%, IDYA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4728.99% in the prior-year period — up 98.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting IDYA's profit margin (-74.75%), review year-over-year change from -4728.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.